Proteomics International Laboratories Ltd (ASX:PIQ)
Australia
· Delayed Price · Currency is AUD 0.3800
0.00 (0.00%)
May 2, 2025, 3:58 PM AEST
ASX:PIQ Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2015 - 2019 |
| Operating Revenue | 0.95 | 0.89 | 0.73 | 1.49 | 1.31 | 1.42 | Upgrade
|
| Other Revenue | 2.55 | 2.38 | 2.45 | 1.94 | 1.42 | 1.31 | Upgrade
|
| Revenue | 3.5 | 3.28 | 3.18 | 3.43 | 2.74 | 2.73 | Upgrade
|
| Revenue Growth (YoY) | 15.29% | 3.00% | -7.26% | 25.39% | 0.25% | 1.52% | Upgrade
|
| Cost of Revenue | 2.04 | 2.02 | 2.35 | 2.06 | 0.81 | 0.84 | Upgrade
|
| Gross Profit | 1.46 | 1.26 | 0.84 | 1.37 | 1.92 | 1.89 | Upgrade
|
| Selling, General & Admin | 6.19 | 5.88 | 5.82 | 4.91 | 3.77 | 2.89 | Upgrade
|
| Other Operating Expenses | 0.69 | 0.61 | 0.53 | 0.51 | 0.71 | 0.52 | Upgrade
|
| Operating Expenses | 8.86 | 8 | 7.2 | 6.35 | 5 | 3.89 | Upgrade
|
| Operating Income | -7.4 | -6.74 | -6.37 | -4.98 | -3.08 | -2 | Upgrade
|
| Interest Expense | -0.04 | -0.02 | - | -0 | -0.01 | -0.02 | Upgrade
|
| Interest & Investment Income | 0.29 | 0.28 | 0.14 | 0.01 | 0.01 | 0.02 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.02 | -0.02 | -0.02 | 0 | -0.02 | -0.01 | Upgrade
|
| EBT Excluding Unusual Items | -7.17 | -6.5 | -6.25 | -4.97 | -3.1 | -2.01 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 0.02 | 0.01 | - | 0.01 | - | Upgrade
|
| Other Unusual Items | - | - | - | - | 0.23 | 0.27 | Upgrade
|
| Pretax Income | -7.17 | -6.48 | -6.23 | -4.97 | -2.86 | -1.74 | Upgrade
|
| Earnings From Continuing Operations | -7.17 | -6.48 | -6.23 | -4.97 | -2.86 | -1.74 | Upgrade
|
| Minority Interest in Earnings | 0.06 | 0.11 | 0.06 | - | - | - | Upgrade
|
| Net Income | -7.11 | -6.38 | -6.18 | -4.97 | -2.86 | -1.74 | Upgrade
|
| Net Income to Common | -7.11 | -6.38 | -6.18 | -4.97 | -2.86 | -1.74 | Upgrade
|
| Shares Outstanding (Basic) | 138 | 126 | 116 | 106 | 102 | 87 | Upgrade
|
| Shares Outstanding (Diluted) | 138 | 126 | 116 | 106 | 102 | 87 | Upgrade
|
| Shares Change (YoY) | 23.44% | 8.07% | 10.35% | 3.76% | 16.34% | 8.83% | Upgrade
|
| EPS (Basic) | -0.05 | -0.05 | -0.05 | -0.05 | -0.03 | -0.02 | Upgrade
|
| EPS (Diluted) | -0.05 | -0.05 | -0.05 | -0.05 | -0.03 | -0.02 | Upgrade
|
| Free Cash Flow | -5.51 | -6 | -6.91 | -3.67 | -2.41 | -1.84 | Upgrade
|
| Free Cash Flow Per Share | -0.04 | -0.05 | -0.06 | -0.04 | -0.02 | -0.02 | Upgrade
|
| Gross Margin | 41.64% | 38.49% | 26.27% | 40.01% | 70.25% | 69.27% | Upgrade
|
| Operating Margin | -211.77% | -205.74% | -200.11% | -145.10% | -112.68% | -73.22% | Upgrade
|
| Profit Margin | -203.39% | -194.62% | -194.17% | -144.98% | -104.53% | -63.90% | Upgrade
|
| Free Cash Flow Margin | -157.64% | -183.02% | -217.25% | -106.97% | -88.25% | -67.53% | Upgrade
|
| EBITDA | -6.74 | -6.11 | -5.84 | -4.56 | -2.77 | -1.7 | Upgrade
|
| EBITDA Margin | -192.76% | -186.60% | -183.46% | -132.95% | -101.40% | -62.24% | Upgrade
|
| D&A For EBITDA | 0.66 | 0.63 | 0.53 | 0.42 | 0.31 | 0.3 | Upgrade
|
| EBIT | -7.4 | -6.74 | -6.37 | -4.98 | -3.08 | -2 | Upgrade
|
| EBIT Margin | -211.77% | -205.74% | -200.11% | -145.10% | -112.68% | -73.22% | Upgrade
|
| Revenue as Reported | 0.21 | - | - | - | - | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.